Cordyceps for Health & Longevity - Quick Reference Sheet

Cordyceps for Health & Longevity

Created on 06/17/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A traditional caterpillar fungus, now mostly lab-grown, valued as a stamina tonic. The best-supported benefit for active adults is a modest gain in aerobic endurance after several weeks of higher-dose use. There is reasonable evidence it nudges immune-cell activity upward; longevity claims stay speculative. The main concern is product quality, not the fungus itself. (Full Review)

Protocol

Standard Dose
1–4 g/day
Cordyceps militaris extract or fermented mycelium, taken daily
Duration
≥3–6 weeks
Taken daily before judging effect; benefits are not acute
Titration
Start ~1 g/day
Titrate up to the studied 3–4 g/day range over 1–2 weeks
Time to effect
Aerobic Endurance
~3 weeks
Exercise benefits appear after roughly 3 weeks or more of daily dosing
Immune Signaling
4–8 weeks
NK-cell activity rises over 4–8 weeks; men by 4 weeks, women by 8

Benefits

Contraindications
  • Autoimmune disease
  • Organ-transplant recipients on immunosuppression
  • Bleeding disorders or scheduled surgery (discontinue ≥2 weeks prior)
  • Pregnant or breastfeeding individuals
  • Poorly controlled diabetes on medication without monitoring
Key Interactions
  • Anticoagulant and antiplatelet drugs (warfarin, apixaban, rivaroxaban, clopidogrel, aspirin)
  • Antidiabetic medications (insulin, sulfonylureas, metformin)
  • Immunosuppressants (cyclosporine, tacrolimus, corticosteroids)
  • Over-the-counter NSAIDs and aspirin (ibuprofen, naproxen, aspirin)
  • Supplement interactions (fish oil, ginkgo, garlic, vitamin E, berberine, chromium, alpha-lipoic acid)
  • Other interventions (mushroom blends with reishi, lion's mane)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Heavy metal & adulterant contamination; mild gastrointestinal effects
  • Low: Bleeding risk / antiplatelet effect; immune stimulation in autoimmune conditions; hypoglycemia (additive)
  • Speculative: Allergic / hypersensitivity reactions; drug-metabolism interactions

Monitoring

Marker Target Why
Fasting glucose 75–86 mg/dL Detects additive glucose-lowering, especially if on diabetes medication
HbA1c < 5.4% Tracks longer-term glucose effect
eGFR > 90 mL/min/1.73m² Relevant for those using Cordyceps for kidney support or with chronic kidney disease
Serum creatinine 0.6–1.0 mg/dL Primary kidney marker improved in CKD trials
hs-CRP < 1.0 mg/L Captures the anti-inflammatory/immune signal
CBC with platelets Within standard lab range Screens immune/blood effects and bleeding risk
Heavy metals (blood/urine arsenic) Below detectable/regulatory limits Surveillance for contamination with long-term use

Cadence: Baseline before the first dose; recheck at ~3 months, then every 6–12 months for long-term users; more frequent glucose checks in the first few weeks for those on diabetes medication.

Qualitative Assessment

  • Perceived endurance and exercise tolerance (e.g., ability to sustain a given pace or intensity)
  • Energy levels and resistance to fatigue across the day
  • Recovery quality after intense exercise
  • Frequency and duration of minor illnesses (a rough proxy for immune effect)
  • Subjective stamina and sense of vitality